The aim of our study was to investigate the effect of individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression on the objective efficacy and survival conditions of patients with unresectable pancreatic cancer. This evidence concerns the gene BRCA1 and pancreatic neoplasm.